You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海正藥業(600267.SH)擬對參股子公司博鋭生物等比例增資2.1億元
格隆匯 01-21 16:53

格隆匯1月21日丨海正藥業(600267.SH)公佈,2021年1月20日,公司第八屆董事會第二十二次會議審議通過了《關於對參股子公司浙江博鋭生物製藥有限公司增資的議案》,同意公司以現金方式對博鋭生物進行同比例增資,增資金額共為人民幣5億元,其中公司增資2.1億元,太盟增資2.75億元,品瞻增資1500萬元。本次增資完成後,公司、PAG Highlander (HK) Limited(以下簡稱“太盟”)和上海品瞻企業諮詢管理中心(有限合夥)(以下簡稱“品瞻”)持股比例不變,分別為42%、55%、3%。本次增資完成後,可加速博鋭生物生物創新藥的研發速度,保障其未來的產能擴張,有利於博鋭生物的順利發展。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account